More than 700 employees will be based at the Kendall Square location in Cambridge. Already, IBM has entered into partnerships with various institutions to expand the opportunities for Watson Health.
Advertisement
The collaboration will enable the pharmaceutical firm to access IBM’s Watson Health Cloud in order to aid patients and healthcare providers.
“The most ambitious of these is probably the new Watson Health Cloud for Life Sciences Compliance”. The Watson Health Cloud attempts to collect large amounts of patient data and make it easier for doctors and companies to make health decisions.
The two companies will also create a joint Teva-IBM research team that will use big data to create disease models and advanced therapeutic solutions.
“Teva is actively exploring the e-health evolution with a strong focus on fulfilling unmet and emerging patients’ needs”.
In April IBM said that it would be steering its Watson computer system towards health data, and would base those operations in Massachusetts.
Teva joins Sage Bionetworks in declaring Watson Health Cloud as their preferred development platforms.
Watson Care Manager integrates capabilities from Watson Health, Apple’s Healthkit and ResearchKit letting researchers use iPhones for a range of purposes. The Health Cloud has been identifying, sharing and combining it with a dynamic and constantly growing aggregated view of clinical, research and social health data.
ICON is applying Watson to clinical trial matching. Together with IBM, we are also providing a better and faster way to connect patients with clinical trials that are most relevant to them. Additionally, as trials become more complex which increasing eligibility criteria, fewer patients match the medical profiles sought. Columbia is the 16th cancer center to test the use Watson Genomic Analytics to bring medicine to patients worldwide. They join existing partners that include CVS Health, Medtronic and Yale University leverage Watson’s capabilities for drug discovery and development, personalized medicine, chronic disease management, pediatrics and digital health.
At IBM, DiSanzo will lead a huge division: an organization of 2,000 people, an IBM spokesperson told Business Insider.
Deborah DiSanzo, who served as CEO of Philips Healthcare for two years until 2014, is now IBM Watson Health’s GM, according to Business Insider.
Advertisement
All of these moves, taken together, advance the strategy that IBM senior vice president Mike Rhodin described in a prepared statement as “driving a new era of health, enabling entrepreneurs and industry leaders to address diverse needs, spanning the earliest stages of research all the way through to clinical care and population health through to consumer wellness”.
